How should I manage a 48-year-old woman with low serum iron, low transferrin saturation, low‑normal ferritin, normal red blood cell indices, markedly elevated red cell distribution width, and borderline hemoglobin (12.2 g/dL)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Iron Deficiency in a 48-Year-Old Woman

This patient has iron deficiency (transferrin saturation 10%, low serum iron 35 µg/dL) requiring both iron replacement therapy and urgent gastrointestinal investigation to identify the underlying cause, as unexplained iron deficiency in a postmenopausal woman warrants fast-track evaluation for potential GI malignancy. 1

Diagnostic Interpretation

Your patient's labs confirm absolute iron deficiency based on:

  • Transferrin saturation of 10% (markedly below the 20% threshold) 2
  • Serum iron of 35 µg/dL (low-normal range)
  • Ferritin of 38 ng/mL (below the recommended 45 ng/mL cutoff for diagnosing iron deficiency in anemic patients) 2
  • Hemoglobin 12.2 g/dL (borderline low for women, reference 11.1-15.9 g/dL)
  • Markedly elevated RDW of 19.4% (reference 11.7-15.4%), which indicates significant red cell size variation consistent with evolving iron deficiency 3

The normal MCV (86 fL) does not exclude iron deficiency—iron deficiency anemia can present with normocytic indices early in its course, and the elevated RDW suggests a mixed population of cells as iron stores become depleted 4, 3. The ferritin of 38 ng/mL is definitively low and diagnostic of iron deficiency in the absence of inflammation 2.

Immediate Management Steps

1. Initiate Iron Replacement Therapy

Start oral iron supplementation immediately with ferrous sulfate 325 mg daily (or on alternate days if better tolerated) 2, 4. The goal is to:

  • Achieve a hemoglobin rise of ≥10 g/L (≥1 g/dL) within 2 weeks, which confirms iron deficiency even if initial iron studies were equivocal 1
  • Improve quality of life by addressing fatigue, exercise intolerance, and other iron deficiency symptoms 4

Practical considerations for oral iron 2:

  • Take on an empty stomach for optimal absorption
  • If not tolerated, take with meals (preferably with meat protein)
  • Add 500 mg vitamin C to enhance absorption
  • Alternate-day dosing may improve tolerance with similar efficacy

2. Urgent Gastrointestinal Investigation

This patient requires bidirectional endoscopy (gastroscopy and colonoscopy) as first-line investigation 1. As a postmenopausal woman with unexplained iron deficiency, she is at risk for GI malignancy, which can present with iron deficiency even without overt GI symptoms 1.

Specific evaluations to include 1, 2:

  • Celiac disease screening (tissue transglutaminase antibodies or duodenal biopsy at gastroscopy)—found in 3-5% of iron deficiency cases 1
  • Helicobacter pylori testing during upper endoscopy 2
  • Urinalysis to exclude urinary blood loss 1
  • Detailed menstrual history (though postmenopausal status makes this less likely)

If colonoscopy is not feasible, CT colonography is a reasonable alternative 1.

When to Consider Intravenous Iron

Switch to IV iron if 2, 4:

  • Oral iron is not tolerated (nausea, abdominal pain, constipation)
  • Inadequate hemoglobin response after 4 weeks of oral therapy (failure to rise ≥1-2 g/dL)
  • Malabsorption is identified (celiac disease, atrophic gastritis, post-bariatric surgery)
  • Ongoing blood loss is documented
  • Chronic inflammatory conditions are present (though your patient's normal inflammatory markers make this less likely)

Follow-Up and Monitoring

Recheck hemoglobin in 4 weeks 5:

  • If hemoglobin increases by 1-2 g/dL, continue oral iron until ferritin >100 µg/L 6
  • If inadequate response, consider malabsorption, ongoing blood loss, or unidentified lesion 5

If bidirectional endoscopy is negative and iron deficiency recurs or persists 1:

  • Consider wireless capsule endoscopy to evaluate the small bowel for occult bleeding sources (angioectasias, small bowel lesions)
  • Reassess for malabsorption disorders

Critical Pitfalls to Avoid

  • Do not dismiss this as "just low iron"—unexplained iron deficiency in postmenopausal women requires cancer exclusion 1
  • Do not rely solely on MCV—iron deficiency can present with normal MCV, especially early; the elevated RDW is the key clue here 3
  • Do not delay endoscopy while treating with iron—investigation and treatment should proceed in parallel 1
  • Do not accept ferritin 38 ng/mL as "normal"—this is diagnostic of iron deficiency in your patient 2

Treatment Targets

Aim for 6:

  • Hemoglobin normalization (>12 g/dL for women)
  • Ferritin >100 µg/L to replete iron stores
  • Transferrin saturation >20%

Related Questions

With high serum iron and high total iron‑binding capacity (TIBC) but low ferritin, should I take over‑the‑counter iron supplements?
How should low ferritin with normal serum iron be evaluated and treated?
What is the significance of a ferritin of 31 ng/mL and a transferrin saturation of 19 %, and what treatment is recommended?
Should serum ferritin be checked in patients with peripheral neuropathy, and if low, how should iron deficiency be treated?
How should I manage a patient with ferritin 60 ng/mL, transferrin saturation 21 %, total iron‑binding capacity 398 µg/dL, who has been on oral ferrous sulfate for 14 months and now has a recent small gastrointestinal bleed?
Is a tirzepatide dose of 2.5 mg subcutaneously every two weeks appropriate for weight loss and as a maintenance dose?
For an adult with acute cardiac tamponade, what is the recommended intravenous isotonic crystalloid fluid management, including type, volume, monitoring, and adjunctive therapy, prior to definitive pericardial drainage?
What is the mechanism of action of pectin as a soluble dietary fiber?
What is the recommended starting dose and titration schedule of olanzapine (generic) for an adult with schizophrenia presenting with acute psychosis, and what monitoring is required?
What is the appropriate dose of fondaparinux for deep vein thrombosis (DVT) prophylaxis in an obese adult with normal renal function and no contraindications to anticoagulation?
What are the items of the Cambridge‑Hopkins Restless Legs Syndrome questionnaire (CH‑RLSq)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.